These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26234938)

  • 1. An MRI Method To Map Tumor Hypoxia Using Red Blood Cells Loaded with a pO2-Responsive Gd-Agent.
    Di Gregorio E; Ferrauto G; Gianolio E; Lanzardo S; Carrera C; Fedeli F; Aime S
    ACS Nano; 2015 Aug; 9(8):8239-48. PubMed ID: 26234938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of multiparametric MRI maps by using Gd-labelled- RBCs reveals phenotypes and stages of murine prostate cancer.
    Ferrauto G; Di Gregorio E; Lanzardo S; Ciolli L; Iezzi M; Aime S
    Sci Rep; 2018 Jul; 8(1):10567. PubMed ID: 30002426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gd-loaded-RBCs for the assessment of tumor vascular volume by contrast-enhanced-MRI.
    Ferrauto G; Di Gregorio E; Dastrù W; Lanzardo S; Aime S
    Biomaterials; 2015 Jul; 58():82-92. PubMed ID: 25941785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography.
    Yang CT; Chandrasekharan P; He T; Poh Z; Raju A; Chuang KH; Robins EG
    Biomaterials; 2014 Jan; 35(1):327-36. PubMed ID: 24138829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi's sarcoma.
    Grange C; Geninatti-Crich S; Esposito G; Alberti D; Tei L; Bussolati B; Aime S; Camussi G
    Cancer Res; 2010 Mar; 70(6):2180-90. PubMed ID: 20215497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and biodistribution study of self-assembled Gd-micelles demonstrating blood-pool contrast enhancement for MRI.
    Vorobiev V; Babič A; Crowe LA; Van De Looij Y; Lenglet S; Thomas A; Helm L; Vallée JP; Allémann E
    Int J Pharm; 2019 Sep; 568():118496. PubMed ID: 31279053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium-based contrast agent.
    Chen SH; Kuo YT; Cheng TL; Chen CY; Chiu YY; Lai JJ; Chang CC; Jaw TS; Wang YM; Liu GC
    Kaohsiung J Med Sci; 2013 May; 29(5):246-53. PubMed ID: 23639510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential passage of gadolinium through the mouse inner ear barriers evaluated with 4.7T MRI.
    Zou J; Zhang W; Poe D; Zhang Y; Ramadan UA; Pyykkö I
    Hear Res; 2010 Jan; 259(1-2):36-43. PubMed ID: 19818391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive MRI detection of internalized T1 contrast agents using magnetization transfer contrast.
    Delli Castelli D; Ferrauto G; Di Gregorio E; Terreno E; Aime S
    NMR Biomed; 2015 Dec; 28(12):1663-70. PubMed ID: 26474109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonosensitive theranostic liposomes for preclinical in vivo MRI-guided visualization of doxorubicin release stimulated by pulsed low intensity non-focused ultrasound.
    Rizzitelli S; Giustetto P; Cutrin JC; Delli Castelli D; Boffa C; Ruzza M; Menchise V; Molinari F; Aime S; Terreno E
    J Control Release; 2015 Mar; 202():21-30. PubMed ID: 25626083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast enhanced lung MRI in mice using ultra-short echo time radial imaging and intratracheally administrated Gd-DOTA-based nanoparticles.
    Bianchi A; Lux F; Tillement O; Crémillieux Y
    Magn Reson Med; 2013 Nov; 70(5):1419-26. PubMed ID: 23233439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study.
    de Smet M; Heijman E; Langereis S; Hijnen NM; Grüll H
    J Control Release; 2011 Feb; 150(1):102-10. PubMed ID: 21059375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative dynamic contrast-enhanced MRI in tumor-bearing rats and mice with inversion recovery TrueFISP and two contrast agents at 4.7 T.
    Weidensteiner C; Rausch M; McSheehy PM; Allegrini PR
    J Magn Reson Imaging; 2006 Sep; 24(3):646-56. PubMed ID: 16878308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4.
    Fruytier AC; Magat J; Neveu MA; Karroum O; Bouzin C; Feron O; Jordan B; Cron GO; Gallez B
    NMR Biomed; 2014 Nov; 27(11):1403-12. PubMed ID: 25323069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-high field 1H magnetic resonance imaging approaches for acute hypoxia.
    Nielsen T; Nielsen NC; Holm TH; Ostergaard L; Horsman MR; Busk M
    Acta Oncol; 2013 Oct; 52(7):1287-92. PubMed ID: 23992112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gd-DOTA loaded into red blood cells, a new magnetic resonance imaging contrast agents for vascular system.
    Kravtzoff R; Urvoase E; Chambon C; Ropars C
    Adv Exp Med Biol; 1992; 326():347-54. PubMed ID: 1295322
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood oxygenation level dependent, blood volume, and blood flow responses to carbogen and hypoxic hypoxia in 9L rat gliomas as measured by MRI.
    Jerome NP; Hekmatyar SK; Kauppinen RA
    J Magn Reson Imaging; 2014 Jan; 39(1):110-9. PubMed ID: 23553891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo MRI multicontrast kinetic analysis of the uptake and intracellular trafficking of paramagnetically labeled liposomes.
    Delli Castelli D; Dastrù W; Terreno E; Cittadino E; Mainini F; Torres E; Spadaro M; Aime S
    J Control Release; 2010 Jun; 144(3):271-9. PubMed ID: 20230865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadolinium chelate with DO3A conjugated 2-(diphenylphosphoryl)-ethyldiphenylphosphonium cation as potential tumor-selective MRI contrast agent.
    Chandrasekharan P; Yong CX; Poh Z; He T; He Z; Liu S; Robins EG; Chuang KH; Yang CT
    Biomaterials; 2012 Dec; 33(36):9225-31. PubMed ID: 23026708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved tumor-targeting MRI contrast agents: Gd(DOTA) conjugates of a cycloalkane-based RGD peptide.
    Park JA; Lee YJ; Ko IO; Kim TJ; Chang Y; Lim SM; Kim KM; Kim JY
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):246-50. PubMed ID: 25449282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.